However, intranasal ASC secretome treatment significantly lowered the IL-4 and IL-5 levels in the sinonasal mucosa of the CRS + PBS group (p = 0.027 and p = 0.023, respectively). This evidence concerns the gene IL4 and congenital rubella syndrome.